Profile
// What About Us
Muktar Aliyu, MD, DrPH, MPH
VIGH Associate Director for Research; Associate Professor of Health Policy and Medicine at Vanderbilt; and Associate Professor of Family and Community Medicine at Meharry Medical College
// About Me
Biography
Biography
Dr. Aliyu is Associate Professor of Health Policy and Medicine with Vanderbilt University Medical Center and Associate Director (Research) of the Vanderbilt Institute for Global Health. Dr. Aliyu attended medical school in Nigeria and completed graduate training in public health at the George Washington University and the University of Alabama at Birmingham. He joined Vanderbilt University after completing preventive medicine residency and fellowship training at Meharry Medical College and the Mayo Clinic. Dr. Aliyu’s research interests are in improving timely linkage and retention in HIV care, especially for prevention of mother-to-child HIV transmission programs. He is a principal investigator on research and training grants from the U.S. National Institutes of Health.Â
More About Muktar Aliyu, MD, DrPH, MPH
I am a physician epidemiologist and have been involved in the prevention and treatment of HIV/AIDS for over a decade, including service, research and capacity building efforts. For 5½ years I served as the program director for Vanderbilt University’s comprehensive HIV program in Nigeria that was funded through the U.S. President’s Plan for Emergency Relief (PEPFAR). My research work has focused on the optimal approaches to delivering quality clinical services in resource-constrained settings, especially for patients with HIV/AIDS. My 170-plus peer-reviewed articles (Google Scholar® h-index = 35, i10 index = 90) include work on delayed initiation of antiretroviral therapy, male participation in prevention of mother-to-child HIV transmission, suboptimal entry into early infant diagnosis, antiretroviral treatment initiation, and pioneering studies on spousal participation in perinatal care in African settings. I served as the PI of a recently completed cluster randomized R01 focused on optimizing outcomes for HIV-infected mothers and their exposed infants using a family-focused package of PMTCT interventions. More recently I have been the co-principal investigator of a large NIH-funded clinical trial examining the use of ACE inhibitors for prevention of chronic kidney disease in persons with HIV in Nigeria. I currently serve as the Global Health lead on the TN-CFAR Executive Committee and look forward to continue serving in this role.